A549 cells infected with IAV Analysis Results (GEO series: GSE147507)
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr14_-_23791484 Show fit | 1.03 |
ENST00000594872.1
|
Uncharacterized protein |
|
chr4_+_76649753 Show fit | 0.74 |
ENST00000603759.1
|
USO1 vesicle transport factor |
|
chr16_+_53242350 Show fit | 0.68 |
ENST00000565442.1
|
chromodomain helicase DNA binding protein 9 |
|
chr11_+_110001723 Show fit | 0.49 |
ENST00000528673.1
|
zinc finger CCCH-type containing 12C |
|
chr17_+_70026795 Show fit | 0.43 |
ENST00000472655.2
ENST00000538810.1 |
long intergenic non-protein coding RNA 1152 |
|
chr7_-_27219849 Show fit | 0.35 |
ENST00000396344.4
|
homeobox A10 |
|
chr17_+_76037081 Show fit | 0.35 |
ENST00000588549.1
|
trinucleotide repeat containing 6C |
|
chr5_+_149865377 Show fit | 0.35 |
ENST00000522491.1
|
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 |
|
chr6_+_12008986 Show fit | 0.30 |
ENST00000491710.1
|
human immunodeficiency virus type I enhancer binding protein 1 |
|
chr22_+_37959647 Show fit | 0.29 |
ENST00000415670.1
|
CDC42 effector protein (Rho GTPase binding) 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.8 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.5 | GO:0048165 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.1 | 0.5 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) myoblast fate commitment(GO:0048625) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.0 | 0.4 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.4 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.0 | 0.4 | GO:0060065 | uterus development(GO:0060065) |
0.0 | 0.3 | GO:0072619 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.0 | 0.3 | GO:1903788 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
0.0 | 0.3 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.0 | 0.3 | GO:0097338 | response to clozapine(GO:0097338) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.8 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 0.5 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) beta-catenin-TCF complex(GO:1990907) |
0.0 | 0.5 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.0 | 0.3 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
0.0 | 0.3 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.3 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.2 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.0 | 0.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.2 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.6 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.5 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.0 | 0.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.3 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.0 | 0.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.2 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.6 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |